Psychological function in a randomized trial of continuous nitroglycerin for menopausal hot flashes

Area of Science:

• Reproductive Medicine
• Psychiatry
• Clinical Pharmacology

Background:

• Menopausal women frequently experience hot flashes and associated psychological symptoms, impacting quality of life.
• Continuous transdermal nitroglycerin has been explored as a potential treatment for hot flashes.

Purpose of the Study:

• To assess the effect of continuous transdermal nitroglycerin on psychological function in menopausal women.
• To investigate the relationship between hot flash frequency and psychological symptoms.

Main Methods:

• A 12-week randomized, placebo-controlled trial involving menopausal women with frequent hot flashes.
• Psychological function assessed using validated scales: CES-D, GAD-7, and MENQOL Psychosocial Subscale.
• Statistical analysis using linear mixed models to evaluate treatment effects and symptom associations.

Main Results:

• Nitroglycerin therapy did not significantly improve depression (CES-D) or anxiety (GAD-7) scores compared to placebo.
• Increased hot flash frequency was linked to worse anxiety (GAD-7) scores.
• Improvement in hot flashes correlated with better Menopause-Specific Quality of Life (MENQOL) psychosocial scores, but not consistently with mood scores.

Conclusions:

• Continuous transdermal nitroglycerin did not demonstrate consistent benefits for mood symptoms in menopausal women experiencing hot flashes.
• Clinicians should consider multifactorial influences on midlife psychological well-being beyond hot flash frequency.